ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,310
Screening encounters
3,825
Diagnostic referrals
727
Outstanding pathways
279

Screening pathway

  1. Screening3,825Encounters
  2. Positive finding1,322Documented findings
  3. Referral727Diagnostic referrals
  4. Follow-up848Diagnostic visits
  5. Outcome448Resolved pathways

Stage totals use different units. Pending pathways: 279. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0652 · EXP-0652Synthetic · Site A

Full participant history through 2026-08-14, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2025-08-17
  4. · Diagnostic referral · EXP-0652-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Barrier documented · Appointment coordination
  8. · Barrier documented · Contact difficulty
  9. · Diagnostic visit · Missed
  10. · Diagnostic booking · Rebooking
  11. · Navigation intervention · Coordination support
  12. · Diagnostic visit · Attended
  13. · Diagnosis · Colposcopy · Biopsy collected
  14. · Diagnosis · Histopathology · No high-grade lesion identified
  15. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-05-05
  16. · Follow-up disposition · Resolved · EXP-0652-T-R
  17. · Screening · HPV DNA · Repeat · Prior VIA positive
  18. · Screening result · HPV DNA · HPV not detected · Adequate
  19. · Surveillance · HPV DNA · Surveillance · After clinical assessment
  20. · Surveillance result · HPV DNA · HPV detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

3310 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0556 · Expanded synthetic participant 0556Site E — Resource-Constrained Navigation Programme
EXP-0557 · Expanded synthetic participant 0557Site A — Urban Referral Hub
EXP-0558 · Expanded synthetic participant 0558Site B — Peri-Urban Access Programme
EXP-0559 · Expanded synthetic participant 0559Site B — Peri-Urban Access Programme
EXP-0560 · Expanded synthetic participant 0560Site E — Resource-Constrained Navigation Programme
EXP-0561 · Expanded synthetic participant 0561Site A — Urban Referral Hub
EXP-0562 · Expanded synthetic participant 0562Site C — Rural Outreach Programme
EXP-0566 · Expanded synthetic participant 0566Site E — Resource-Constrained Navigation Programme
EXP-0567 · Expanded synthetic participant 0567Site C — Rural Outreach Programme
EXP-0568 · Expanded synthetic participant 0568Site A — Urban Referral Hub
EXP-0569 · Expanded synthetic participant 0569Site D — Community Engagement Programme
EXP-0571 · Expanded synthetic participant 0571Site E — Resource-Constrained Navigation Programme
EXP-0572 · Expanded synthetic participant 0572Site A — Urban Referral Hub
EXP-0573 · Expanded synthetic participant 0573Site C — Rural Outreach Programme
EXP-0575 · Expanded synthetic participant 0575Site C — Rural Outreach Programme
EXP-0577 · Expanded synthetic participant 0577Site D — Community Engagement Programme
EXP-0578 · Expanded synthetic participant 0578Site E — Resource-Constrained Navigation Programme
EXP-0580 · Expanded synthetic participant 0580Site D — Community Engagement Programme
EXP-0582 · Expanded synthetic participant 0582Site E — Resource-Constrained Navigation Programme
EXP-0583 · Expanded synthetic participant 0583Site A — Urban Referral Hub
EXP-0584 · Expanded synthetic participant 0584Site C — Rural Outreach Programme
EXP-0585 · Expanded synthetic participant 0585Site B — Peri-Urban Access Programme
EXP-0586 · Expanded synthetic participant 0586Site A — Urban Referral Hub
EXP-0587 · Expanded synthetic participant 0587Site A — Urban Referral Hub
EXP-0588 · Expanded synthetic participant 0588Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
1512
HPV DNA
1766
Cytology
547

Navigation activity

Barrier documented
632
Contact attempt
1072
Navigation intervention
270
Diagnostic booking
897
Diagnostic visit
848

Documented barriers

Contact difficulty
210
Transport difficulty
198
Appointment coordination
224

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.